Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines.
In humans, four tropomyosin genes (TPM1, TPM2, TPM3, and TPM4) are known to produce a multitude of isoforms via alternate splicing and/or using alternate promoters. Expression of tropomyosin has been shown to be modulated at both the transcription and the translational levels. Tropomyosins are known to make up some of the stress fibers of human epithelial cells and differences in their expression has been demonstrated in malignant breast epithelial cell lines compared to 'normal' breast cell lines. We have recently reported the expression of four novel TPM1 isoforms (TPM1λ, TPM1µ, TPM1ν, and TPM1ξ) from human malignant tumor breast cell lines that are not expressed in adult and fetal cardiac tissue. Also, we evaluated their expression in relation to the stress fiber formation. In this study, nine malignant breast epithelial cell lines and three 'normal' breast cell lines were examined for stress fiber formation and expression of tropomyosin 2 (TPM2) isoform-specific RNAs and proteins. Stress fiber formation was assessed by immunofluorescence using Leica AF6000 Deconvolution microscope. Stress fiber formation was strong (++++) in the 'normal' cell lines and varied among the malignant cell lines (negative to +++). No new TPM2 gene RNA isoforms were identified, and TPM2β was the most frequently expressed TPM2 RNA and protein isoform. Stress fiber formation positively correlated with TPM2β RNA or protein expression at high, statistically significant degrees. Previously, we had shown that TPM1δ and TPM1λ positively and inversely, respectively, correlated with stress fiber formation. The most powerful predictor of stress fiber formation was the combination of TPM2β RNA, TPM1δ RNA, and the inverse of TPM1λ RNA expression. Our results suggest that the increased expression of TPM1λ and the decreased expression of TPM1δ RNA and TPM2β may lead to decreased stress fiber formation and malignant transformation in human breast epithelial cells.
Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Syamalima
S
Dube
Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Anish
A
Thomas
Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Lynn
L
Abbott
Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Patricia
P
Benz
Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Charles
C
Mitschow
Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Dipak K
DK
Dube
Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Bernard J
BJ
Poiesz
D017398:Alternative Splicing; D002471:Cell Transformation, Neoplastic; D005260:Female; D015870:Gene Expression; D006801:Humans; D061986:MCF-7 Cells; D020033:Protein Isoforms / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D022502:Stress Fibers / Q000378:metabolism; D014335:Tropomyosin / Q000096:biosynthesis* / Q000235:genetics
D020033:Protein Isoforms; D012333:RNA, Messenger; C518659:TPM2 protein, human; D014335:Tropomyosin